...NF1, TET2, and BCOR, suggesting an additional level of complexity and contribution to leukemic transformation. EZH2 emer...
...NF1]), providing an additional link between these tumors and the mitogen-activated protein kinase (MAPK) signaling pathw...
...NF1 mutations are described as the major melanoma drivers, but approximately 20% of patients lack these mutations and ar...
...NF1). The identification of additional mutated genes in this rare subset of tumors can have important clinical benefit t...
...NF1 and NF2, have been reported in children with JXG. Recent whole-exome sequencing of JXG cases did not show the BRAF-V...
...NF1, a gonadosomatic mosaic in WT1 and two pathogenic variants in one patient (DICER1 and PALB2). TGS allows a more deta...
...NF1 (n = 2), PTPN11 (n = 1), CBL (n = 1), and BRAF (n = 1). None of these patients had clinical findings to guide a cand...
...NF1 gene combined with CD3+ cells above 28.6% (p = 0.006) and MUM1+ cells above 21.8% (p < 0.001). Moreover, patients wi...
...NF1, and TET2 were identified only in cases with type A transcript. Myeloblasts of AML with CBFB rearrangement are posit...
...NF1, and TP53 each. When assessing the clinical data, each of the 5 patients had one or more different types of cancers,...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
